Market Exclusive

Analyst Activity – Stifel Nicolaus Initiates Coverage On Protagonist Therapeutics (NASDAQ:PTGX) With a Buy

Analyst Ratings For Protagonist Therapeutics (NASDAQ:PTGX)

Today, Stifel Nicolaus initiated coverage on Protagonist Therapeutics (NASDAQ:PTGX) with a Buy with a price target of $32.00.

Some recent analyst ratings include

Recent Insider Trading Activity For Protagonist Therapeutics (NASDAQ:PTGX)
Protagonist Therapeutics (NASDAQ:PTGX) has insider ownership of 15.50% and institutional ownership of 41.86%.

Recent Trading Activity for Protagonist Therapeutics (NASDAQ:PTGX)
Shares of Protagonist Therapeutics closed the previous trading session at 21.50 up +2.27 11.80% with shares trading hands.

Exit mobile version